{
  "title": "Risks of Using Cannabinoids",
  "itunes:title": "Risks of Using Cannabinoids",
  "pubDate": "Sat, 02 Apr 2022 16:00:20 +0000",
  "guid": "891afa2a-3cc1-425d-948a-e89a3e83d3ce",
  "link": "https://psychopharmacology.libsyn.com/risks-of-using-cannabinoids",
  "itunes:image": "",
  "description": "<p>What are the risks associated with cannabinoid use? This episode discusses some risks, such as overdose, increased ER visits, and cardiovascular risks as well as the effects on pulmonary health. </p> <p>Faculty: Diana Martinez, M.D. <br /> Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.</p> <ul> <li><strong><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC150\"> Learn more about our memberships here</a></strong></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/medicinal-cannabis-and-the-psychiatric-patient-clinical-harm-vs-novel-treatment-2614?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC150\"> <strong>Earn 0.75 CMEs: Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/cannabinoids-risks-for-patients-2614-5107?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC150\"> <strong>Cannabinoids and Risks for Patients</strong></a></li> </ul> <p> </p>",
  "content:encoded": "<p>What are the risks associated with cannabinoid use? This episode discusses some risks, such as overdose, increased ER visits, and cardiovascular risks as well as the effects on pulmonary health. </p> <p>Faculty: Diana Martinez, M.D.  Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC150\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/medicinal-cannabis-and-the-psychiatric-patient-clinical-harm-vs-novel-treatment-2614?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC150\"> Earn 0.75 CMEs: Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/cannabinoids-risks-for-patients-2614-5107?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC150\"> Cannabinoids and Risks for Patients</a></li> </ul> <p> </p>",
  "enclosure": "",
  "itunes:duration": "10:22",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "What are the risks associated with cannabinoid use? This episode discusses some risks, such as overdose, increased ER visits, and cardiovascular risks as well as the effects on pulmonary health.  Faculty: Diana Martinez, M.D.  Hosts: Jessica...",
  "itunes:episodeType": "full"
}